Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The impact of timing of adjuvant therapy on survival for patients with glioblastoma: An analysis of the National Cancer Database.

Amsbaugh MJ, Yusuf M, Gaskins J, Burton E, Woo S.

J Clin Neurosci. 2019 Aug;66:92-99. doi: 10.1016/j.jocn.2019.05.013. Epub 2019 May 16.

PMID:
31104962
2.

Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.

Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, Flieder DB, Ridge JA.

J Clin Oncol. 2016 Jan 10;34(2):169-78. doi: 10.1200/JCO.2015.61.5906. Epub 2015 Nov 30.

3.

The impact of adjuvant chemoradiotherapy timing on survival of head and neck cancers.

Tam M, Wu SP, Gerber NK, Lee A, Schreiber D, Givi B, Hu K.

Laryngoscope. 2018 Oct;128(10):2326-2332. doi: 10.1002/lary.27152. Epub 2018 Feb 26.

PMID:
29481712
4.

Survival Impact of Time to Initiation of Adjuvant Radiation for Merkel Cell Carcinoma: An Analysis of the National Cancer Database.

Yusuf M, Gaskins J, Tennant P, Bumpous J, Dunlap N.

Pract Radiat Oncol. 2019 Jul - Aug;9(4):e372-e385. doi: 10.1016/j.prro.2019.03.004. Epub 2019 Mar 26.

PMID:
30926480
5.

Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival.

Pollom EL, Fujimoto DK, Han SS, Harris JP, Tharin SA, Soltys SG.

J Radiat Res. 2018 Mar 1;59(suppl_1):i11-i18. doi: 10.1093/jrr/rrx103.

6.

Impact of Timing of Adjuvant Chemoradiation for Glioblastoma in a Large Hospital Database.

Osborn VW, Lee A, Garay E, Safdieh J, Schreiber D.

Neurosurgery. 2018 Nov 1;83(5):915-921. doi: 10.1093/neuros/nyx497.

PMID:
29092047
7.

Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model.

Audureau E, Chivet A, Ursu R, Corns R, Metellus P, Noel G, Zouaoui S, Guyotat J, Le Reste PJ, Faillot T, Litre F, Desse N, Petit A, Emery E, Lechapt-Zalcman E, Peltier J, Duntze J, Dezamis E, Voirin J, Menei P, Caire F, Dam Hieu P, Barat JL, Langlois O, Vignes JR, Fabbro-Peray P, Riondel A, Sorbets E, Zanello M, Roux A, Carpentier A, Bauchet L, Pallud J; Club de Neuro-Oncologie of the Société Française de Neurochirurgie.

J Neurooncol. 2018 Feb;136(3):565-576. doi: 10.1007/s11060-017-2685-4. Epub 2017 Nov 20.

PMID:
29159777
8.

The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.

Han SJ, Rutledge WC, Molinaro AM, Chang SM, Clarke JL, Prados MD, Taylor JW, Berger MS, Butowski NA.

Neurosurgery. 2015 Aug;77(2):248-53; discussion 253. doi: 10.1227/NEU.0000000000000766.

9.

Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients.

Louvel G, Metellus P, Noel G, Peeters S, Guyotat J, Duntze J, Le Reste PJ, Dam Hieu P, Faillot T, Litre F, Desse N, Petit A, Emery E, Voirin J, Peltier J, Caire F, Vignes JR, Barat JL, Langlois O, Menei P, Dumont SN, Zanello M, Dezamis E, Dhermain F, Pallud J; Club de Neuro-Oncologie of Société Française deNeurochirurgie.

Radiother Oncol. 2016 Jan;118(1):9-15. doi: 10.1016/j.radonc.2016.01.001. Epub 2016 Jan 11.

PMID:
26791930
10.

Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area.

Liang H, Xiang YQ, Lv X, Xie CQ, Cao SM, Wang L, Qian CN, Yang J, Ye YF, Gan F, Ke LR, Yu YH, Liu GY, Qiu WZ, Huang XJ, Wen CH, You N, Wang XQ, Guo X, Xia WX.

Eur J Cancer. 2017 Mar;73:48-60. doi: 10.1016/j.ejca.2016.12.009. Epub 2017 Feb 3.

PMID:
28161498
11.

Determining the Optimal Timing for Initiation of Adjuvant Chemotherapy After Resection for Stage II and III Colon Cancer.

Sun Z, Adam MA, Kim J, Nussbaum DP, Benrashid E, Mantyh CR, Migaly J.

Dis Colon Rectum. 2016 Feb;59(2):87-93. doi: 10.1097/DCR.0000000000000518.

PMID:
26734965
12.

Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.

Sun MZ, Oh T, Ivan ME, Clark AJ, Safaee M, Sayegh ET, Kaur G, Parsa AT, Bloch O.

J Neurosurg. 2015 May;122(5):1144-50. doi: 10.3171/2014.9.JNS14193. Epub 2015 Mar 13.

PMID:
25768833
13.

Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.

Paravati AJ, Heron DE, Landsittel D, Flickinger JC, Mintz A, Chen YF, Huq MS.

J Neurooncol. 2011 Aug;104(1):339-49. doi: 10.1007/s11060-010-0499-8. Epub 2010 Dec 22.

14.

Patterns of care and outcomes for glioblastoma in patients with poor performance status.

Malakhov N, Lee A, Garay E, Becker DJ, Schreiber D.

J Clin Neurosci. 2018 Jun;52:66-70. doi: 10.1016/j.jocn.2018.03.006. Epub 2018 Mar 22.

PMID:
29576419
15.

Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.

Amsbaugh MJ, Yusuf MB, Gaskins J, Burton EC, Woo SY.

Cancer. 2017 Sep 1;123(17):3277-3284. doi: 10.1002/cncr.30730. Epub 2017 Apr 27.

16.

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, Reni M, Brandes AA, Curschmann J, Villa S, Cairncross G, Allgeier A, Lacombe D, Stupp R.

J Clin Oncol. 2006 Jun 1;24(16):2563-9.

PMID:
16735709
17.

Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.

Niranjan A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD.

J Neurosurg. 2015 Apr;122(4):757-65. doi: 10.3171/2014.11.JNS13295. Epub 2015 Jan 16.

PMID:
25594327
18.

A Comparative Analysis of the Usefulness of Survival Prediction Models for Patients with Glioblastoma in the Temozolomide Era: The Importance of Methylguanine Methyltransferase Promoter Methylation, Extent of Resection, and Subventricular Zone Location.

Woo P, Ho J, Lam S, Ma E, Chan D, Wong WK, Mak C, Lee M, Wong ST, Chan KY, Poon WS.

World Neurosurg. 2018 Jul;115:e375-e385. doi: 10.1016/j.wneu.2018.04.059. Epub 2018 Apr 17.

PMID:
29678708
19.

Survival improvements with adjuvant therapy in patients with glioblastoma.

Jayamanne D, Wheeler H, Cook R, Teo C, Brazier D, Schembri G, Kastelan M, Guo L, Back MF.

ANZ J Surg. 2018 Mar;88(3):196-201. doi: 10.1111/ans.14153. Epub 2017 Sep 18.

PMID:
28922698
20.

Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response.

Turner MC, Keenan JE, Rushing CN, Gulack BC, Nussbaum DP, Benrashid E, Hyslop T, Strickler JH, Mantyh CR, Migaly J.

J Gastrointest Surg. 2019 Jan 11. doi: 10.1007/s11605-018-04079-8. [Epub ahead of print]

PMID:
30635829

Supplemental Content

Support Center